恩威斯塔控股 NVST

Paul Keel, Background: President and Chief Executive Officer of the Company since May 2024, Chief Executive Officer of Smiths Group plc, a global technology company and FTSE constituent, from May 2021 to March 2024 and 3M Company - Group President, Consumer Business Group, March 2019 to August 2020, President, 3M Medical Solutions, President, 3M Unitek/3M Oral Care and Various senior leadership positions from 2004 through August 2020.

Eric Hammes, joined Envista in July 2024 and is our Senior Vice President and Chief Financial Officer. Prior to that, Mr. Hammes served as Vice President, Corporate Financial Planning & Analysis of Rockwell Automation, a global industrial automation company from August 2023 to July 2024. Prior to that, Mr. Hammes served at 3M Company as Executive Vice President, Chief Country Governance and Services Officer from January 2022 to May 2023, Executive Vice President, Enterprise Operations from April 2019 to December 2021, Executive Vice President, Business Transformation & IT from June 2017 to April 2019, and Senior Vice President, Controller and Chief Accounting Officer from April 2014 to April 2017. Mr. Hammes joined 3M in 1997 and held various financial and leadership roles including CFO of 3M Health Care Business Group, Director Finance of 3M Orthodontic Products Division, and Senior Vice President, International Finance.

Mark E. Nance, has served as our Senior Vice President, General Counsel and Secretary since September 2019. Prior to that, Mr. Nance served as the Chief Legal Officer of INSYS Therapeutics, Inc., a pharmaceutical company, from October 2018 to July 2019 and Special Advisor to FIPRA International, Ltd., a public affairs consultancy company, from July 2017 to July 2019. Prior to joining INSYS Therapeutics, Inc., Mr. Nance served as the Senior Vice President and Global General Counsel of Mylan N.V., a pharmaceutical company, from April 2012 to May 2017. Prior to joining Mylan N.V., Mr. Nance served as General Counsel of GE Healthcare Medical Diagnostics and GE Healthcare Life Sciences. In addition, Mr. Nance has held various other leadership positions and roles in industry and in government, including the U.S. Federal Trade Commission.

Veronica Acurio, joined Envista in August 2024 and is our President, Orthodontics. Prior to that, Ms. Acurio served as Senior Vice President, Medical Solution Division of Solventum Corporation from April 2024 to August 2024. Prior to that, she served as President of 3M's $5 billion Medical Solutions Division from October 2022 to March 2024 and as SVP of 3M Health Care in the Greater China region from January 2020 to October 2022. Prior to that, she held various commercial, operational, and business leadership roles around the world including Managing Director of 3M Taiwan, VP Business Development of 3M Health Care for Latin America, and Global Business Director of 3M Oral Care Division's Restorative business.

Scott Huennekens, Background: President and Chief Executive Officer of Hyperfine, Inc., a publicly traded medical technology company, from July 2022 until October 2022, President, Chief Executive Officer, and Chairman of Verb Surgical, Inc., a medical equipment manufacturer, from August 2015 to January 2019, President and Chief Executive Officer of Volcano Corporation, a medical device company (publicly traded until its acquisition by Royal Philips in 2015), from 2002 until February 2015, Current Board Member and Compensation Committee Member of QuidelOrtho Corporation, a publicly traded global provider of diagnostic solutions, Current Board Member and Audit Committee Member of NeuroPace, Inc., a publicly traded medical device company and Previously Held Public Company Directorships: NuVasive, Inc., Hyperfine, Inc. (Chair), Acutus Medical, Inc. (Chair), ViewRay, Inc., Reva Medical Inc., EndoChoice Holdings, Volcano Corporation, and Bellerophon Therapeutics Inc.

Christine Tsingos, Background: Executive Vice President and Chief Financial Officer of Bio-Rad Laboratories, Inc., a publicly traded manufacturer of life science research and clinical diagnostics products, from 2002 to May 2019, Prior to 2002, Ms. Tsingos held executive positions at Autodesk, Inc., The Cooper Companies, Inc. and Attest Systems, Inc., Board member, Audit Committee Chair, and Compensation Committee member of Varex Imaging Corporation, a publicly traded X-ray imaging systems company and Previously Held Public Company Directorships: Onto Innovation Inc. (Audit Committee Chair and member of the Compensation Committee) and Telesis Bio Inc. (Audit Committee Chair).

Wendy Carruthers, Background: Executive Vice President of Human Resources from February 2022 until February 2025, Senior Vice President of Human Resources from December 2012 until February 2022 and Various Human Resources roles from 2004 until 2012, including Vice President of Human Resources for Europe, Middle East and Africa, Fellow of Chartered Institute of Personnel and Development (CIPD).

Kieran T. Gallahue, Background: CareFusion Corporation - Chairman and Chief Executive Officer from 2011 until 2015, ResMed Inc - Chief Executive Officer from 2008 to 2011, President from 2004 to 2011 and President and Chief Operating Officer, Americas, from 2003 to 2004, Current Board Member and Audit Committee Member of Edwards Lifesciences Corp., a publicly traded medical device manufacturer., Previously Held Public Company Directorships: Arena Pharmaceuticals, Inc., Intersect ENT, Inc. (Chair), CareFusion Corporation (Chair), Volcano Corporation, and ResMed Inc. Served on the Board and Executive Committee of Advanced Medical Technology Association (AdvaMed), a medical device trade association.

Vivek Jain, Background: Chairman and Chief Executive Officer of ICU Medical, Inc., a publicly traded global medical technology company specializing in infusion therapy, since February 2014, CareFusion Corporation - President of Procedural Solutions from 2011 to February 2014 and President, Medical Technologies and Services, from September 2009 to 2011; Executive Vice President-Strategy and Corporate Development of Cardinal Health, Inc., a publicly traded health care services company, from June 2007 until August 2009, Senior Vice President, Business Development and M&A for the Philips Medical Systems business of Koninklijke Philips Electronics N.V., a publicly traded electronics company, from 2006 to August 2007 and Investment banker at J.P. Morgan Securities, Inc., an investment banking firm, from 1994 to 2006. Mr. Jain's last position with J.P. Morgan was as Co-Head of Global Healthcare Investment Banking from 2002 to 2006. .

Daniel A. Raskas, Background: Danaher Corporation - Senior Vice President, Corporate Development from 2010 to April 2025 and Vice President, Corporate Development from 2004 to 2010; Managing Director for Thayer Capital Partners, a private equity investment firm, prior to joining Danaher and Co-Founder of W50 LLC, a strategy and M&A consulting company.

J. Andrew Pierce, Background: Stryker Corporation- Group President, MedSurg & Neurotechnology, since August 2019, Group President, MedSurg from 2018 to 2019, President, Endoscopy from 2013 to 2018, Vice President and General Manager, Surgical and Neuro Spine ENT from 2011 to 2013, Vice President and General Manager, Surgical from 2009 to 2011, Vice President and General Manager, Stryker Craniomaxillofacial from 2008 to 2009 and Various other leadership roles within Stryker from 1996.

On June 2, 2026, the Company appointed Coree Thomas, the Company's Vice President, Global Controller, as the Company's Vice President and Chief Accounting Officer. He will assume that role and act as the principal accounting officer, effective as of August 6, 2026. Mr. Thomas, has served as the Company's Vice President, Global Controller since joining the Company in February 2023. From October 2021 to February 2023, Mr. Thomas served as Vice President, Global Controller of CBRE Group, Inc. (CBRE). Prior to that, he served as VP Corporate Controller & Global Segment Controller - Advisory at CBRE from April 2021 to September 2021. Before joining CBRE in 2020, Mr. Thomas held various leadership positions at Edwards Lifesciences Corporation, Exelon Corporation, and KPMG LLP. He has a Bachelor of Science in Accounting from St. Mary's College of California.

Mischa M. Reis, has served as our Senior Vice President, Strategy and Corporate Development since September 2019. Prior to that, Mr. Reis served as Vice President, Business Development & Strategy of Danaher's Dental business since October 2012.